BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37318648)

  • 1. Prediction of HER2 status via random forest in 3257 Chinese patients with gastric cancer.
    Tian S; Yu R; Zhou F; Zhan N; Li J; Wang X; Peng X
    Clin Exp Med; 2023 Dec; 23(8):5015-5024. PubMed ID: 37318648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
    Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning models to predict in-hospital mortality in septic patients with diabetes.
    Qi J; Lei J; Li N; Huang D; Liu H; Zhou K; Dai Z; Sun C
    Front Endocrinol (Lausanne); 2022; 13():1034251. PubMed ID: 36465642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer.
    Xu M; Liu S; Li L; Qiao X; Ji C; Tan L; Zhou Z
    Sci Rep; 2022 Aug; 12(1):14177. PubMed ID: 35986169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2.
    Wu J; Zhao Q; Zhao Y; Zhang X; Tian Y; Guo Z
    Sci Rep; 2021 Mar; 11(1):6993. PubMed ID: 33772068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer.
    Xiao Y; Ding J; Ma D; Chen S; Li X; Yu K
    Front Immunol; 2022; 13():877825. PubMed ID: 35663978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE).
    Qin S; Ji J; Xu RH; Wang W; Tang Y; Bi F; Li J; Wang K; Xu JM; Fan Q; Su W; Shen L
    Oncologist; 2021 Sep; 26(9):e1567-e1580. PubMed ID: 34003545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of nomogram of peritoneal metastasis in gastric cancer based on simplified clinicopathological features and serum tumor markers.
    Yang J; Su H; Chen T; Chen X; Chen H; Li G; Yu J
    BMC Cancer; 2023 Jan; 23(1):64. PubMed ID: 36653759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
    Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
    EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT Radiomics for Distinction of Human Epidermal Growth Factor Receptor 2 Negative Gastric Cancer.
    Wang Y; Yu Y; Han W; Zhang YJ; Jiang L; Xue HD; Lei J; Jin ZY; Yu JC
    Acad Radiol; 2021 Mar; 28(3):e86-e92. PubMed ID: 32303442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of lymphovascular and perineural invasion in gastric cancer using spectral computed tomography imaging and machine learning.
    Ge HT; Chen JW; Wang LL; Zou TX; Zheng B; Liu YF; Xue YJ; Lin WW
    World J Gastroenterol; 2024 Feb; 30(6):542-555. PubMed ID: 38463023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer.
    Li Y; Cheng Z; Gevaert O; He L; Huang Y; Chen X; Huang X; Wu X; Zhang W; Dong M; Huang J; Huang Y; Xia T; Liang C; Liu Z
    Chin J Cancer Res; 2020 Feb; 32(1):62-71. PubMed ID: 32194306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning model based on multi-lesion and time series CT images for predicting the benefits from anti-HER2 targeted therapy in stage IV gastric cancer.
    He M; Chen ZF; Liu S; Chen Y; Zhang H; Zhang L; Zhao J; Yang J; Zhang XT; Shen L; Gao JB; Dong B; Tang L
    Insights Imaging; 2024 Feb; 15(1):59. PubMed ID: 38411839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radiomics-based model for prediction of lymph node metastasis in gastric cancer.
    Gao X; Ma T; Cui J; Zhang Y; Wang L; Li H; Ye Z
    Eur J Radiol; 2020 Aug; 129():109069. PubMed ID: 32464581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer.
    Ock CY; Lee KW; Kim JW; Kim JS; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Kim WH; Bang YJ; Oh DY
    Clin Cancer Res; 2015 Jun; 21(11):2520-9. PubMed ID: 25712681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
    Cho JH; Lim JY; Cho JY
    World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.